Vildagliptin, a well-established DPP-4 inhibitor, plays a crucial role in managing type 2 diabetes globally. As the demand for effective diabetes medications continues to rise, suppliers of vildagliptin seek reliable buyers across diverse regions and industries. This article empowers you with a comprehensive guide to navigate the global vildagliptin market, connecting you with potential partners worldwide. Global Landscape of Vildagliptin Buyers: NOVARTIS HEALTHCARE PRIVATE LIMITED NOVARTIS FARMACEUTICA SA DE CV CÔNG TY TNHH NOVARTIS VIỆT NAM QUALIS PHARMA S A C NOVARTIS SAGLIK GIDAVE TARIM URUNL SAN VE TIC A S ACTIVE FINE CHEMICALS LTD TECNOFARMA S A CÔNG TY TNHH DƯỢC PHẨM VÀ TRANG THIẾT BỊ Y TẾ HOÀNG…